Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 65

1.

Is vancomycine still a choice for chronic osteomyelitis empirical therapy in iran?

Izadi M, Zamani MM, Mousavi SA, Sadat SM, Siami Z, Vais Ahmadi N, Jonaidi Jafari N, Shirvani S, Majidi Fard M, Imani Fooladi AA.

Iran Red Crescent Med J. 2012 Dec;14(12):782-6. doi: 10.5812/ircmj.2165.

3.

[Detection methods for drug-resistant bacteria in routine examination--VISA].

Kinoshita S, Nakamachi Y.

Rinsho Byori. 2000 Jan;Suppl 111:69-74. Review. Japanese.

PMID:
10804795
4.

Mupirocin resistance among Iranian isolates of Staphylococcus aureus.

Saderi H, Owlia P, Habibi M.

Med Sci Monit. 2008 Oct;14(10):BR210-3.

PMID:
18830185
5.

Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA).

Appelbaum PC.

Int J Antimicrob Agents. 2007 Nov;30(5):398-408. Review.

PMID:
17888634
6.

Methicillin resistant and susceptible Staphylococcus aureus: Appraising therapeutic approaches in the Northwest of Iran.

Hasani A, Sheikhalizadeh V, Hasani A, Naghili B, Valizadeh V, Nikoonijad AR.

Iran J Microbiol. 2013 Mar;5(1):56-62.

7.

Current pattern of antibiotic resistance in Staphylococcus aureus clinical isolates and the emergence of vancomycin resistance.

Taj Y, Abdullah FE, Kazmi SU.

J Coll Physicians Surg Pak. 2010 Nov;20(11):728-32. doi: 11.2010/JCPSP.728732.

PMID:
21078245
8.

[Surveillance on gram-positive bacteria isolated from patients with hospital acquired infections or community acquired infections].

Li JT, Li Y, Wang J; China Bacterial Resistance Surveillance Study Group..

Zhonghua Yi Xue Za Zhi. 2003 Mar 10;83(5):365-74. Chinese.

PMID:
12820911
9.

Occurrence of vancomycin-intermediate-resistant Staphylococcus aureus in Japan.

Hanaki H, Hososaka Y, Yanagisawa C, Otsuka Y, Nagasawa Z, Nakae T, Sunakawa K.

J Infect Chemother. 2007 Apr;13(2):118-21.

PMID:
17458681
10.

[Investigation of reduced vancomycin susceptibility in methicillin-resistant staphylococci].

Kuşcu F, Oztürk DB, Gürbüz Y, Tütüncü EE, Sencan I, Gül S.

Mikrobiyol Bul. 2011 Apr;45(2):248-57. Turkish.

PMID:
21644067
11.

Relevance of vancomycin-intermediate susceptibility and heteroresistance in methicillin-resistant Staphylococcus aureus bacteraemia.

Khatib R, Jose J, Musta A, Sharma M, Fakih MG, Johnson LB, Riederer K, Shemes S.

J Antimicrob Chemother. 2011 Jul;66(7):1594-9. doi: 10.1093/jac/dkr169.

PMID:
21525024
12.

Effectiveness of hydroxyapatite-vancomycin bone cement in the treatment of Staphylococcus aureus induced chronic osteomyelitis.

Joosten U, Joist A, Gosheger G, Liljenqvist U, Brandt B, von Eiff C.

Biomaterials. 2005 Sep;26(25):5251-8.

PMID:
15792552
13.

Detection Methods of Glycopeptide-Resistant Staphylococcus aureus I : Susceptibility Testing.

Hanaki H, Hiramatsu K.

Methods Mol Med. 2001;48:85-91. doi: 10.1385/1-59259-077-2:85.

PMID:
21374408
14.

MRSA--the tip of the iceberg.

Appelbaum PC.

Clin Microbiol Infect. 2006 Apr;12 Suppl 2:3-10. Review.

15.
16.

In vitro activity of omiganan pentahydrochloride tested against vancomycin-tolerant, -intermediate, and -resistant Staphylococcus aureus.

Fritsche TR, Rhomberg PR, Sader HS, Jones RN.

Diagn Microbiol Infect Dis. 2008 Apr;60(4):399-403. doi: 10.1016/j.diagmicrobio.2007.11.004.

PMID:
18178361
18.

Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia.

Soriano A, Marco F, Martínez JA, Pisos E, Almela M, Dimova VP, Alamo D, Ortega M, Lopez J, Mensa J.

Clin Infect Dis. 2008 Jan 15;46(2):193-200. doi: 10.1086/524667.

PMID:
18171250
19.

[Clinical relevance of hetero-VRSA in surgical infections].

Okii K, Takesue Y, Yokoyama T.

Nihon Rinsho. 2001 Apr;59(4):728-32. Review. Japanese.

PMID:
11304997
20.

Vancomycin MICs did not creep in Staphylococcus aureus isolates from 2002 to 2006 in a setting with low vancomycin usage.

Alós JI, García-Cañas A, García-Hierro P, Rodríguez-Salvanés F.

J Antimicrob Chemother. 2008 Oct;62(4):773-5. doi: 10.1093/jac/dkn246.

PMID:
18552338

Supplemental Content

Support Center